Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nkx2-9
|
ENSMUSG00000058669.7 | NK2 homeobox 9 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_56611867_56612018 | Nkx2-9 | 1342 | 0.263063 | 0.32 | 1.7e-02 | Click! |
chr12_56614584_56614735 | Nkx2-9 | 1375 | 0.298565 | 0.23 | 8.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_34899052_34899209 | 15.33 |
Pank1 |
pantothenate kinase 1 |
19675 |
0.15 |
chr5_147993062_147993354 | 14.64 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
35866 |
0.15 |
chr8_26946995_26947146 | 13.75 |
Gm45572 |
predicted gene 45572 |
19364 |
0.11 |
chr9_63563534_63563685 | 13.72 |
Gm16759 |
predicted gene, 16759 |
32257 |
0.14 |
chr4_100101880_100102395 | 13.24 |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
6346 |
0.22 |
chr6_37423542_37423693 | 12.80 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
18529 |
0.25 |
chr17_13654565_13655321 | 11.03 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr18_36342380_36342857 | 10.84 |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
38 |
0.98 |
chr2_148018222_148018401 | 10.73 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
19959 |
0.17 |
chr17_73072507_73072892 | 10.71 |
Lclat1 |
lysocardiolipin acyltransferase 1 |
35286 |
0.16 |
chr4_105364618_105364769 | 10.55 |
Gm12722 |
predicted gene 12722 |
10253 |
0.3 |
chr13_60504328_60504479 | 10.52 |
A530001N23Rik |
RIKEN cDNA A530001N23 gene |
15595 |
0.15 |
chr13_67763034_67763223 | 10.47 |
Zfp85 |
zinc finger protein 85 |
7900 |
0.09 |
chr9_14105009_14105160 | 10.22 |
1700019J19Rik |
RIKEN cDNA 1700019J19 gene |
1492 |
0.39 |
chr8_9055663_9055852 | 10.17 |
4933430N04Rik |
RIKEN cDNA 4933430N04 gene |
76531 |
0.08 |
chr6_91389110_91389432 | 10.13 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
22092 |
0.11 |
chr10_96736026_96736179 | 10.11 |
Gm48507 |
predicted gene, 48507 |
24295 |
0.16 |
chr4_133104265_133104462 | 10.07 |
Wasf2 |
WAS protein family, member 2 |
26142 |
0.14 |
chr12_17742999_17743158 | 10.01 |
Hpcal1 |
hippocalcin-like 1 |
14852 |
0.22 |
chr3_148136924_148137087 | 9.98 |
Gm43574 |
predicted gene 43574 |
6761 |
0.34 |
chr5_35135917_35136219 | 9.89 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
30302 |
0.16 |
chr10_111559059_111559247 | 9.87 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
35120 |
0.11 |
chr5_77126519_77126711 | 9.68 |
Gm15831 |
predicted gene 15831 |
4267 |
0.15 |
chr18_58344690_58345061 | 9.67 |
Gm25660 |
predicted gene, 25660 |
113300 |
0.07 |
chr7_112309752_112310043 | 9.59 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
6132 |
0.3 |
chr14_65404115_65404582 | 9.57 |
Zfp395 |
zinc finger protein 395 |
8668 |
0.19 |
chr14_121103439_121103812 | 9.56 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
1546 |
0.53 |
chrX_50968307_50968473 | 9.46 |
Frmd7 |
FERM domain containing 7 |
25680 |
0.19 |
chr9_99709969_99710283 | 9.43 |
Cldn18 |
claudin 18 |
63 |
0.96 |
chr8_91987831_91988212 | 9.25 |
Gm36670 |
predicted gene, 36670 |
3848 |
0.19 |
chr14_64816226_64816459 | 9.15 |
Hmbox1 |
homeobox containing 1 |
5954 |
0.17 |
chr1_73992293_73993185 | 9.01 |
Tns1 |
tensin 1 |
2633 |
0.33 |
chr1_79932415_79932709 | 9.01 |
Gm5529 |
predicted pseudogene 5529 |
9136 |
0.21 |
chr8_11384955_11385106 | 8.89 |
Col4a2 |
collagen, type IV, alpha 2 |
19878 |
0.15 |
chr1_155693534_155693775 | 8.83 |
Acbd6 |
acyl-Coenzyme A binding domain containing 6 |
6663 |
0.21 |
chr8_71645645_71645796 | 8.67 |
Unc13a |
unc-13 homolog A |
233 |
0.84 |
chr8_83458314_83458676 | 8.66 |
Scoc |
short coiled-coil protein |
104 |
0.95 |
chr9_48707810_48708095 | 8.61 |
Nnmt |
nicotinamide N-methyltransferase |
102799 |
0.06 |
chr12_76046714_76046865 | 8.57 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
1789 |
0.44 |
chr3_34908627_34908778 | 8.57 |
Mir6378 |
microRNA 6378 |
13949 |
0.24 |
chr9_56463721_56463913 | 8.56 |
AC159819.1 |
ubiquitin-conjugating enzyme E2S (Ube2s) retrogene |
26360 |
0.13 |
chr14_8536141_8536296 | 8.56 |
Gm8416 |
predicted gene 8416 |
127301 |
0.05 |
chr1_35095001_35095152 | 8.55 |
Gm25096 |
predicted gene, 25096 |
84008 |
0.08 |
chr6_135363140_135363291 | 8.52 |
Emp1 |
epithelial membrane protein 1 |
147 |
0.95 |
chr9_95257001_95257349 | 8.52 |
Slc9a9 |
solute carrier family 9 (sodium/hydrogen exchanger), member 9 |
135489 |
0.04 |
chr10_45079834_45080145 | 8.48 |
Prep |
prolyl endopeptidase |
12786 |
0.17 |
chrX_96099164_96099322 | 8.46 |
Msn |
moesin |
3146 |
0.29 |
chr9_46016716_46016867 | 8.44 |
Sik3 |
SIK family kinase 3 |
3791 |
0.17 |
chr16_95848554_95849066 | 8.42 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
3040 |
0.25 |
chr16_42781642_42782072 | 8.40 |
4932412D23Rik |
RIKEN cDNA 4932412D23 gene |
93730 |
0.08 |
chr9_67247492_67247646 | 8.37 |
Mir190a |
microRNA 190a |
10843 |
0.21 |
chr12_17316120_17316285 | 8.20 |
Atp6v1c2 |
ATPase, H+ transporting, lysosomal V1 subunit C2 |
7789 |
0.16 |
chr1_79746300_79746469 | 8.17 |
Wdfy1 |
WD repeat and FYVE domain containing 1 |
15337 |
0.16 |
chr8_11371463_11371614 | 8.15 |
Col4a2 |
collagen, type IV, alpha 2 |
33370 |
0.12 |
chr4_76661867_76662090 | 8.13 |
Gm11242 |
predicted gene 11242 |
30165 |
0.21 |
chr10_95048905_95049062 | 8.13 |
Gm48867 |
predicted gene, 48867 |
49541 |
0.12 |
chr9_120758118_120758276 | 8.08 |
Gm18101 |
predicted gene, 18101 |
2671 |
0.19 |
chr5_74161228_74161935 | 8.04 |
A330058E17Rik |
RIKEN cDNA A330058E17 gene |
14469 |
0.14 |
chr14_67663552_67663852 | 8.00 |
Gm20667 |
predicted gene 20667 |
11404 |
0.18 |
chrX_5798465_5798751 | 7.86 |
Gm14452 |
predicted gene 14452 |
61109 |
0.1 |
chr11_65322978_65323160 | 7.82 |
Gm12295 |
predicted gene 12295 |
35236 |
0.18 |
chr17_35719766_35719970 | 7.80 |
Ddr1 |
discoidin domain receptor family, member 1 |
15247 |
0.07 |
chrX_5798954_5799105 | 7.78 |
Gm14452 |
predicted gene 14452 |
60688 |
0.1 |
chr10_61386219_61386644 | 7.70 |
Pald1 |
phosphatase domain containing, paladin 1 |
2901 |
0.16 |
chr2_33054117_33054327 | 7.69 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
19438 |
0.15 |
chr7_30291145_30292058 | 7.69 |
Clip3 |
CAP-GLY domain containing linker protein 3 |
127 |
0.89 |
chr4_57067978_57068132 | 7.62 |
Epb41l4b |
erythrocyte membrane protein band 4.1 like 4b |
2504 |
0.33 |
chr19_14894963_14895137 | 7.60 |
Gm5513 |
predicted pseudogene 5513 |
65716 |
0.15 |
chr1_62070743_62070894 | 7.51 |
Gm29641 |
predicted gene 29641 |
24521 |
0.21 |
chr7_112289469_112289834 | 7.51 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
18352 |
0.26 |
chr12_25120867_25121018 | 7.50 |
Gm17746 |
predicted gene, 17746 |
8232 |
0.16 |
chr11_100403477_100403812 | 7.49 |
Gm12348 |
predicted gene 12348 |
2136 |
0.13 |
chr10_86211993_86212399 | 7.48 |
Gm15990 |
predicted gene 15990 |
86369 |
0.06 |
chr3_116414476_116414803 | 7.48 |
Cdc14a |
CDC14 cell division cycle 14A |
8010 |
0.16 |
chr7_121778700_121778876 | 7.47 |
Scnn1g |
sodium channel, nonvoltage-gated 1 gamma |
44309 |
0.12 |
chr15_7352895_7353060 | 7.44 |
Gm16030 |
predicted gene 16030 |
11063 |
0.23 |
chr16_55523301_55523595 | 7.44 |
Mir5118 |
microRNA 5118 |
28717 |
0.22 |
chr5_151251706_151251981 | 7.43 |
5430435K18Rik |
RIKEN cDNA 5430435K18 gene |
462 |
0.82 |
chr13_15602594_15602999 | 7.41 |
Gm48343 |
predicted gene, 48343 |
47139 |
0.16 |
chr14_76698709_76699447 | 7.40 |
1700108F19Rik |
RIKEN cDNA 1700108F19 gene |
17324 |
0.2 |
chr17_33804883_33805035 | 7.37 |
Kank3 |
KN motif and ankyrin repeat domains 3 |
5560 |
0.08 |
chr8_62284797_62285008 | 7.34 |
Gm2961 |
predicted gene 2961 |
90690 |
0.09 |
chr3_30504711_30504894 | 7.32 |
Gm37652 |
predicted gene, 37652 |
989 |
0.46 |
chr14_22746281_22746506 | 7.31 |
Gm7473 |
predicted gene 7473 |
28851 |
0.24 |
chr3_41290546_41290777 | 7.29 |
Gm16508 |
predicted gene 16508 |
71 |
0.98 |
chr9_117234487_117234638 | 7.27 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
17035 |
0.22 |
chr1_136561909_136562079 | 7.24 |
Gm33994 |
predicted gene, 33994 |
17483 |
0.12 |
chr5_76437185_76437354 | 7.23 |
Gm42665 |
predicted gene 42665 |
14505 |
0.15 |
chr7_90125172_90125331 | 7.20 |
2310010J17Rik |
RIKEN cDNA 2310010J17 gene |
4226 |
0.13 |
chr13_98161638_98161789 | 7.17 |
Arhgef28 |
Rho guanine nucleotide exchange factor (GEF) 28 |
14274 |
0.22 |
chr10_88622683_88622890 | 7.15 |
Mybpc1 |
myosin binding protein C, slow-type |
17634 |
0.1 |
chrX_164440232_164440416 | 7.14 |
Asb11 |
ankyrin repeat and SOCS box-containing 11 |
2266 |
0.27 |
chr13_45627470_45627741 | 7.14 |
Gmpr |
guanosine monophosphate reductase |
81452 |
0.1 |
chr2_131845810_131845961 | 7.12 |
Gm14282 |
predicted gene 14282 |
290 |
0.64 |
chrX_162363227_162363562 | 7.12 |
Gm15204 |
predicted gene 15204 |
11798 |
0.27 |
chr13_110643532_110643950 | 7.09 |
Gm33045 |
predicted gene, 33045 |
15745 |
0.23 |
chr10_75200762_75201027 | 7.09 |
Specc1l |
sperm antigen with calponin homology and coiled-coil domains 1-like |
11179 |
0.19 |
chr17_66405003_66405169 | 7.04 |
Gm4705 |
predicted gene 4705 |
8898 |
0.17 |
chr18_83426304_83426622 | 7.02 |
4933401L05Rik |
RIKEN cDNA 4933401L05 gene |
2984 |
0.21 |
chr8_8812341_8812502 | 7.02 |
Gm44622 |
predicted gene 44622 |
76451 |
0.07 |
chr2_142688253_142688404 | 6.99 |
Kif16b |
kinesin family member 16B |
14343 |
0.26 |
chr12_50698834_50699064 | 6.97 |
Prkd1 |
protein kinase D1 |
49851 |
0.16 |
chr8_93181008_93181179 | 6.95 |
Ces1d |
carboxylesterase 1D |
5804 |
0.14 |
chr16_12697258_12697682 | 6.93 |
Gm38619 |
predicted gene, 38619 |
6898 |
0.28 |
chr7_37511349_37511500 | 6.92 |
Gm44882 |
predicted gene 44882 |
6430 |
0.22 |
chr15_73536556_73536709 | 6.91 |
Dennd3 |
DENN/MADD domain containing 3 |
12498 |
0.18 |
chr8_15060693_15060900 | 6.89 |
Myom2 |
myomesin 2 |
606 |
0.59 |
chr3_60267443_60267736 | 6.88 |
Tgif1-ps |
TGFB-induced factor homeobox 1, pseudogene |
75504 |
0.1 |
chr17_3208005_3208156 | 6.85 |
Gm49797 |
predicted gene, 49797 |
9970 |
0.17 |
chr10_77455029_77455180 | 6.85 |
Gm35920 |
predicted gene, 35920 |
2813 |
0.23 |
chr15_94689298_94689449 | 6.83 |
Gm25546 |
predicted gene, 25546 |
7987 |
0.26 |
chr18_61194573_61194724 | 6.83 |
Slc26a2 |
solute carrier family 26 (sulfate transporter), member 2 |
5721 |
0.16 |
chr9_37359459_37360109 | 6.81 |
Hepacam |
hepatocyte cell adhesion molecule |
7567 |
0.11 |
chr8_124182207_124182690 | 6.80 |
Gm3889 |
predicted gene 3889 |
22375 |
0.16 |
chr5_30526362_30526930 | 6.77 |
Gm42765 |
predicted gene 42765 |
2811 |
0.18 |
chr6_67481043_67481194 | 6.76 |
Il23r |
interleukin 23 receptor |
10737 |
0.15 |
chr1_76018983_76019134 | 6.75 |
Gm29065 |
predicted gene 29065 |
302 |
0.94 |
chr8_41015734_41016166 | 6.74 |
Mtus1 |
mitochondrial tumor suppressor 1 |
370 |
0.8 |
chr15_52426087_52426257 | 6.72 |
Gm41322 |
predicted gene, 41322 |
18950 |
0.2 |
chr13_40868871_40869044 | 6.72 |
Mir5124a |
microRNA 5124a |
3166 |
0.14 |
chr19_22469649_22469933 | 6.70 |
Gm27151 |
predicted gene 27151 |
20926 |
0.18 |
chr15_73246575_73246818 | 6.70 |
1700085D07Rik |
RIKEN cDNA 1700085D07 gene |
2850 |
0.22 |
chr14_122453413_122454000 | 6.69 |
Gm5089 |
predicted gene 5089 |
2591 |
0.18 |
chr12_77053145_77053296 | 6.68 |
Gm35189 |
predicted gene, 35189 |
11019 |
0.21 |
chr1_127913298_127913449 | 6.61 |
Rab3gap1 |
RAB3 GTPase activating protein subunit 1 |
9700 |
0.17 |
chr3_104997652_104997803 | 6.61 |
Gm40117 |
predicted gene, 40117 |
3695 |
0.19 |
chr9_54075040_54075209 | 6.61 |
Tnfaip8l3 |
tumor necrosis factor, alpha-induced protein 8-like 3 |
6736 |
0.2 |
chr4_118229188_118229467 | 6.61 |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
1773 |
0.32 |
chr11_115836694_115837008 | 6.60 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
2528 |
0.15 |
chr1_88800548_88800699 | 6.60 |
Platr5 |
pluripotency associated transcript 5 |
45669 |
0.13 |
chr8_27009443_27009594 | 6.58 |
Gm32389 |
predicted gene, 32389 |
1051 |
0.33 |
chr11_8345014_8345192 | 6.55 |
Gm11989 |
predicted gene 11989 |
38750 |
0.21 |
chr9_123085306_123085496 | 6.52 |
Zdhhc3 |
zinc finger, DHHC domain containing 3 |
14948 |
0.1 |
chr18_71004432_71004583 | 6.52 |
Gm50262 |
predicted gene, 50262 |
96856 |
0.09 |
chr13_51314409_51314998 | 6.46 |
Gm6056 |
predicted gene 6056 |
24218 |
0.17 |
chr8_125169873_125170026 | 6.45 |
Gm16237 |
predicted gene 16237 |
57374 |
0.12 |
chr1_72383228_72383379 | 6.44 |
Xrcc5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 |
75876 |
0.08 |
chr12_31835622_31835773 | 6.44 |
Gm48809 |
predicted gene, 48809 |
13929 |
0.17 |
chr2_49797570_49797721 | 6.43 |
Lypd6b |
LY6/PLAUR domain containing 6B |
9914 |
0.21 |
chr10_23086493_23086644 | 6.42 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
28628 |
0.22 |
chr8_61264981_61265132 | 6.39 |
1700001D01Rik |
RIKEN cDNA 1700001D01 gene |
23816 |
0.17 |
chr7_67072044_67072336 | 6.38 |
Gm17909 |
predicted gene, 17909 |
10653 |
0.2 |
chr3_82043846_82043999 | 6.38 |
Gucy1b1 |
guanylate cyclase 1, soluble, beta 1 |
8600 |
0.19 |
chr3_146875965_146876246 | 6.35 |
Ttll7 |
tubulin tyrosine ligase-like family, member 7 |
18071 |
0.19 |
chr4_63916675_63917037 | 6.33 |
Rpl17-ps4 |
ribosomal protein L17, pseudogene 4 |
20757 |
0.2 |
chr2_118180045_118180196 | 6.33 |
Fsip1 |
fibrous sheath-interacting protein 1 |
38031 |
0.11 |
chr4_57561165_57561359 | 6.33 |
Pakap |
paralemmin A kinase anchor protein |
6897 |
0.28 |
chr18_80330855_80331538 | 6.32 |
Gm26676 |
predicted gene, 26676 |
7861 |
0.14 |
chr13_72593690_72593877 | 6.32 |
Gm20554 |
predicted gene, 20554 |
34781 |
0.16 |
chr10_22708533_22708730 | 6.32 |
Tbpl1 |
TATA box binding protein-like 1 |
2246 |
0.25 |
chr5_74136569_74136733 | 6.32 |
A330058E17Rik |
RIKEN cDNA A330058E17 gene |
39399 |
0.09 |
chr3_101596309_101596515 | 6.29 |
Gm42941 |
predicted gene 42941 |
718 |
0.65 |
chr1_136086104_136086255 | 6.29 |
Cacna1s |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
12625 |
0.11 |
chr6_118984439_118984610 | 6.28 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
95483 |
0.08 |
chr12_56265095_56265325 | 6.26 |
Gm47682 |
predicted gene, 47682 |
10812 |
0.16 |
chr6_107566988_107567271 | 6.26 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
37361 |
0.17 |
chr6_88931525_88931802 | 6.26 |
Gm44178 |
predicted gene, 44178 |
11955 |
0.12 |
chr18_85659091_85659276 | 6.25 |
Gm7612 |
predicted gene 7612 |
57542 |
0.17 |
chr19_24046486_24046637 | 6.24 |
Fam189a2 |
family with sequence similarity 189, member A2 |
15542 |
0.16 |
chr6_145457135_145457443 | 6.24 |
Lmntd1 |
lamin tail domain containing 1 |
6522 |
0.16 |
chr5_74692523_74692703 | 6.24 |
Lnx1 |
ligand of numb-protein X 1 |
6826 |
0.18 |
chr9_105764254_105764459 | 6.24 |
Gm38314 |
predicted gene, 38314 |
36571 |
0.14 |
chr19_16168639_16168922 | 6.23 |
E030024N20Rik |
RIKEN cDNA E030024N20 gene |
3975 |
0.26 |
chr8_33826859_33827010 | 6.20 |
Gm26632 |
predicted gene, 26632 |
13731 |
0.15 |
chr5_119480667_119480839 | 6.20 |
Gm31314 |
predicted gene, 31314 |
47201 |
0.15 |
chr3_69375079_69375261 | 6.19 |
Gm17212 |
predicted gene 17212 |
39410 |
0.13 |
chr8_116252769_116252954 | 6.17 |
4930422C21Rik |
RIKEN cDNA 4930422C21 gene |
65492 |
0.13 |
chr11_102603954_102605151 | 6.17 |
Fzd2 |
frizzled class receptor 2 |
156 |
0.91 |
chr17_83803994_83804356 | 6.15 |
Mta3 |
metastasis associated 3 |
8753 |
0.19 |
chr11_35948423_35948795 | 6.14 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
31918 |
0.18 |
chr7_83810171_83810620 | 6.14 |
Gm39043 |
predicted gene, 39043 |
4312 |
0.14 |
chr17_4177609_4177825 | 6.12 |
4930548J01Rik |
RIKEN cDNA 4930548J01 gene |
55604 |
0.16 |
chr6_127897460_127897611 | 6.10 |
Tspan11 |
tetraspanin 11 |
9763 |
0.15 |
chr18_80749307_80749458 | 6.10 |
Atp9b |
ATPase, class II, type 9B |
3614 |
0.23 |
chr11_3686451_3686602 | 6.08 |
Morc2a |
microrchidia 2A |
6164 |
0.12 |
chr1_118913888_118914120 | 6.08 |
Mir6346 |
microRNA 6346 |
40216 |
0.16 |
chr5_76445777_76445928 | 6.08 |
Gm42665 |
predicted gene 42665 |
5922 |
0.18 |
chr15_7352510_7352840 | 6.08 |
Gm16030 |
predicted gene 16030 |
10761 |
0.23 |
chr5_36384914_36385069 | 6.07 |
Sorcs2 |
sortilin-related VPS10 domain containing receptor 2 |
13116 |
0.2 |
chr3_105000743_105000894 | 6.04 |
Gm40117 |
predicted gene, 40117 |
6786 |
0.16 |
chr1_183672635_183672786 | 6.04 |
Gm8214 |
predicted gene 8214 |
9421 |
0.26 |
chr4_137462113_137462322 | 6.01 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
6552 |
0.13 |
chr18_42161842_42162002 | 6.00 |
Cstdc7 |
cystatin domain containing 7 |
11448 |
0.13 |
chr6_118162798_118162949 | 5.98 |
Csgalnact2 |
chondroitin sulfate N-acetylgalactosaminyltransferase 2 |
23733 |
0.14 |
chr14_47958361_47958521 | 5.98 |
Gm49303 |
predicted gene, 49303 |
1578 |
0.35 |
chr13_41343289_41343474 | 5.98 |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated gene 9 |
15866 |
0.13 |
chr12_13845175_13845385 | 5.96 |
Gm49374 |
predicted gene, 49374 |
52943 |
0.11 |
chr1_19321751_19321903 | 5.95 |
Gm28341 |
predicted gene 28341 |
1130 |
0.54 |
chr2_56983190_56983369 | 5.93 |
Gm13527 |
predicted gene 13527 |
96469 |
0.08 |
chr5_74301531_74301691 | 5.93 |
Scfd2 |
Sec1 family domain containing 2 |
13001 |
0.15 |
chr3_36530466_36530660 | 5.92 |
Gm11549 |
predicted gene 11549 |
1768 |
0.23 |
chr12_31719994_31720145 | 5.92 |
Gpr22 |
G protein-coupled receptor 22 |
6122 |
0.17 |
chr3_82980910_82981078 | 5.91 |
Gm30097 |
predicted gene, 30097 |
14591 |
0.15 |
chr13_45960285_45960579 | 5.89 |
Atxn1 |
ataxin 1 |
4525 |
0.21 |
chr14_28456456_28456607 | 5.89 |
Erc2 |
ELKS/RAB6-interacting/CAST family member 2 |
1010 |
0.58 |
chr4_119637406_119637787 | 5.89 |
Guca2a |
guanylate cyclase activator 2a (guanylin) |
108 |
0.96 |
chr12_76004871_76005243 | 5.89 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
17243 |
0.24 |
chr16_30039936_30040304 | 5.89 |
9030404E10Rik |
RIKEN cDNA 9030404E10 gene |
641 |
0.67 |
chr10_42139874_42140025 | 5.88 |
Tdg-ps2 |
thymine DNA glycosylase, pseudogene 2 |
84643 |
0.08 |
chr7_143188732_143188883 | 5.87 |
Gm28821 |
predicted gene 28821 |
48199 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
3.4 | 13.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
3.4 | 13.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
3.2 | 12.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
3.2 | 9.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
3.0 | 9.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.9 | 5.7 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
2.5 | 7.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
2.5 | 19.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
2.4 | 7.3 | GO:0003166 | bundle of His development(GO:0003166) |
2.2 | 8.7 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
2.2 | 6.5 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
2.1 | 6.4 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
2.1 | 23.3 | GO:0032060 | bleb assembly(GO:0032060) |
2.1 | 6.2 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
2.1 | 6.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
2.0 | 6.1 | GO:0021564 | vagus nerve development(GO:0021564) |
2.0 | 6.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.0 | 6.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
2.0 | 6.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.9 | 5.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
1.9 | 5.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.8 | 10.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.8 | 5.4 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.8 | 8.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.8 | 10.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.7 | 8.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.7 | 5.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.7 | 5.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.7 | 5.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.6 | 1.6 | GO:0060437 | lung growth(GO:0060437) |
1.6 | 6.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.6 | 3.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.5 | 6.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.5 | 6.1 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.5 | 1.5 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.5 | 4.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.5 | 10.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.5 | 1.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.5 | 4.5 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
1.5 | 10.3 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
1.5 | 5.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.5 | 1.5 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.5 | 11.6 | GO:0003207 | cardiac chamber formation(GO:0003207) |
1.4 | 1.4 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.4 | 4.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.4 | 4.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.4 | 2.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.4 | 7.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.4 | 4.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.4 | 6.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.4 | 5.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.4 | 4.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.3 | 3.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.3 | 2.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 3.9 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.3 | 1.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.3 | 1.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.3 | 11.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.2 | 7.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.2 | 6.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.2 | 1.2 | GO:0060482 | lobar bronchus development(GO:0060482) |
1.2 | 2.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.2 | 10.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.2 | 1.2 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.2 | 3.6 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
1.2 | 7.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.2 | 7.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.2 | 3.5 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
1.1 | 6.9 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
1.1 | 1.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.1 | 3.4 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.1 | 6.8 | GO:0001705 | ectoderm formation(GO:0001705) |
1.1 | 3.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.1 | 2.3 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.1 | 7.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.1 | 4.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.1 | 3.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.1 | 2.2 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.1 | 3.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.1 | 6.6 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.1 | 3.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.1 | 9.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.1 | 3.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.1 | 1.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.1 | 5.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.0 | 5.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.0 | 1.0 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
1.0 | 3.1 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.0 | 4.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.0 | 2.0 | GO:0060066 | oviduct development(GO:0060066) |
1.0 | 1.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.0 | 2.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.0 | 2.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.0 | 1.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.0 | 4.8 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.9 | 4.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.9 | 2.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.9 | 0.9 | GO:0070384 | Harderian gland development(GO:0070384) |
0.9 | 0.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.9 | 2.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.9 | 1.8 | GO:1900825 | regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.9 | 4.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.9 | 0.9 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.9 | 1.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 3.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.9 | 0.9 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.9 | 2.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 12.7 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.8 | 2.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 1.7 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.8 | 6.7 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.8 | 2.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.8 | 3.3 | GO:0015705 | iodide transport(GO:0015705) |
0.8 | 3.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 2.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.8 | 4.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.8 | 5.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 1.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 4.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.8 | 2.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.8 | 9.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.8 | 2.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.8 | 2.4 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.8 | 2.4 | GO:0015755 | fructose transport(GO:0015755) |
0.8 | 2.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.8 | 3.2 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.8 | 0.8 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.8 | 0.8 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.8 | 1.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.8 | 1.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.8 | 3.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.8 | 1.5 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.8 | 2.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.8 | 2.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.8 | 1.5 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.8 | 2.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.8 | 3.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.8 | 2.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.8 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 5.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 9.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 2.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.7 | 3.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.7 | 3.7 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.7 | 2.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.7 | 0.7 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.7 | 3.7 | GO:0030578 | PML body organization(GO:0030578) |
0.7 | 2.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 2.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 1.4 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.7 | 2.9 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.7 | 3.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.7 | 2.2 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.7 | 5.7 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.7 | 1.4 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.7 | 5.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.7 | 2.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.7 | 2.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.7 | 1.4 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.7 | 2.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.7 | 1.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.7 | 2.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.7 | 1.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.7 | 2.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.7 | 2.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.7 | 1.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 2.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.7 | 5.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.7 | 2.0 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.7 | 2.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.7 | 14.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.7 | 1.4 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 2.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 2.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.7 | 3.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 4.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.7 | 2.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.7 | 1.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.7 | 2.0 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 2.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.7 | 2.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.7 | 2.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 3.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 2.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.7 | 2.0 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.7 | 3.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.6 | 2.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.6 | 1.9 | GO:0010288 | response to lead ion(GO:0010288) |
0.6 | 2.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 3.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.6 | 3.8 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.6 | 1.9 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 2.5 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.6 | 0.6 | GO:0015819 | lysine transport(GO:0015819) |
0.6 | 1.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 1.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.6 | 1.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 3.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.6 | 0.6 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.6 | 1.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.6 | 0.6 | GO:0061042 | vascular wound healing(GO:0061042) |
0.6 | 3.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.6 | 1.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 3.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.6 | 4.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 2.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.6 | 2.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 1.2 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.6 | 3.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 1.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.6 | 1.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.6 | 4.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.6 | 1.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.6 | 2.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.6 | 1.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 1.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 1.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.6 | 1.8 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.6 | 2.3 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.6 | 1.7 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.6 | 2.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.6 | 1.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.6 | 5.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.6 | 2.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.6 | 4.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.6 | 1.2 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.6 | 2.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.6 | 1.1 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 2.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.6 | 1.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.6 | 2.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.6 | 1.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.6 | 1.1 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.6 | 2.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 1.1 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.6 | 0.6 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.6 | 1.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.6 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.5 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 0.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 0.5 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.5 | 1.6 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.5 | 2.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.5 | 1.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.5 | 1.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 1.1 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 1.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 5.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.5 | 2.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 1.6 | GO:0071035 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.5 | 1.1 | GO:1900238 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.5 | 5.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 3.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.5 | 1.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 2.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.5 | 1.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 3.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.5 | 1.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.5 | 4.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.5 | 1.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 2.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 2.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.5 | 1.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.5 | 0.5 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.5 | 2.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 0.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.5 | 0.5 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.5 | 3.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 1.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 3.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.5 | 1.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.5 | 1.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 2.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.5 | 1.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.5 | 1.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 1.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.5 | 1.5 | GO:0030421 | defecation(GO:0030421) |
0.5 | 1.5 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.5 | 4.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.5 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 2.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.5 | 0.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 | 1.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 0.5 | GO:0018158 | protein oxidation(GO:0018158) |
0.5 | 0.9 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.5 | 0.9 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.5 | 1.4 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 1.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 0.5 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.5 | 2.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.5 | 8.4 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.5 | 2.8 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.5 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.8 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 0.9 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.5 | 1.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 0.9 | GO:0033686 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 4.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 2.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.5 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 1.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 0.9 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.4 | 6.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 1.3 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 0.9 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.4 | 0.9 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.4 | 1.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 1.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.4 | 0.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 0.4 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.4 | 0.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 0.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 1.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 3.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.4 | 0.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 5.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.4 | 1.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 0.4 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.4 | 1.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.4 | 1.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.4 | 2.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.4 | 2.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.4 | 1.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 2.6 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 2.6 | GO:0048678 | response to axon injury(GO:0048678) |
0.4 | 0.4 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.4 | 1.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 0.8 | GO:0046959 | habituation(GO:0046959) |
0.4 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.4 | 0.4 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.4 | 1.7 | GO:0019230 | proprioception(GO:0019230) |
0.4 | 2.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 3.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 0.8 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 2.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 0.4 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.4 | 0.8 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 1.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 0.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.4 | 0.4 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.4 | 1.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 1.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 2.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.4 | 0.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 | 0.8 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.4 | 1.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.4 | 1.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.4 | 0.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 1.2 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.4 | 1.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 6.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.4 | 2.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.4 | 1.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.4 | 1.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.4 | 5.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.4 | 0.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.4 | 0.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.4 | 1.2 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.4 | 1.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 2.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 0.4 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.4 | 0.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 1.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 0.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.4 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 5.3 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.4 | 0.7 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 1.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 1.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 0.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.4 | 1.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 1.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 1.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.4 | 2.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.4 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 1.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.4 | 1.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 2.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 1.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 1.8 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.4 | 2.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 0.7 | GO:0033058 | directional locomotion(GO:0033058) |
0.4 | 0.4 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.4 | 0.4 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.4 | 1.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 1.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 1.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 3.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.4 | 0.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 0.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 1.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 0.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 2.8 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.3 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 1.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 1.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.3 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 0.7 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 1.4 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.3 | 0.7 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.3 | 2.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 0.3 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.3 | 1.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 1.6 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.3 | 5.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.3 | 1.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 2.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 1.9 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.3 | 0.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.3 | 2.6 | GO:0042510 | tyrosine phosphorylation of Stat1 protein(GO:0042508) regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.3 | 0.3 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.3 | 0.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 0.3 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.3 | 1.9 | GO:0035878 | nail development(GO:0035878) |
0.3 | 1.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 2.8 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.3 | 1.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 1.9 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.3 | 1.3 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 1.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 1.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.6 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.3 | 2.2 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.3 | 0.9 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 0.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 1.9 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.3 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 0.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 1.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 0.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.3 | 1.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 0.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 0.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 2.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.9 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.3 | 0.9 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 1.2 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.3 | 0.9 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 0.9 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 3.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 0.9 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.3 | 2.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.3 | 0.6 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.3 | 1.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 2.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.3 | 2.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.3 | 1.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 0.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 0.6 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 4.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.3 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 1.1 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 1.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 2.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.3 | 0.6 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.3 | 2.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.3 | 0.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 1.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 1.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 1.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 1.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 0.8 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.3 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 0.8 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 1.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.8 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.3 | 0.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 1.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 0.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 0.8 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.3 | 7.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 1.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.3 | 1.6 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.3 | 1.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 1.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 1.0 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.3 | 0.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 1.0 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.3 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.3 | 2.1 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.3 | 3.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 0.8 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.3 | 0.5 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 0.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 5.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.3 | 0.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 3.6 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.3 | 1.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.3 | 2.5 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.3 | 2.8 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 0.3 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.3 | 0.8 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.3 | 1.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.2 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.2 | 0.5 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.2 | 1.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 1.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 0.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.2 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.2 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 1.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.2 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 2.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 1.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 2.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 1.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 3.5 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.2 | 0.9 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 3.5 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.2 | 1.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 1.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.7 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.2 | 0.7 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.2 | 1.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 3.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 0.5 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 1.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.7 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 1.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 1.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 1.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 0.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 0.7 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 3.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 1.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.4 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.2 | 0.9 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 2.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 1.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.4 | GO:0072307 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 0.4 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.2 | 2.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 1.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.8 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.6 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.8 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 1.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.2 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 0.4 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 1.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 1.2 | GO:0007320 | insemination(GO:0007320) |
0.2 | 1.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 1.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.4 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.2 | 0.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 1.2 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.2 | 0.4 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 0.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 3.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.8 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.2 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 1.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.2 | 0.9 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 0.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 0.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.2 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 4.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.2 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.2 | 2.1 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.2 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.2 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.2 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 1.2 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.2 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 0.2 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 1.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 2.1 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 0.7 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 0.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 3.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 1.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 0.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.3 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.2 | 0.5 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.6 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.5 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.6 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 0.2 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.2 | 1.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.5 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 2.3 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.3 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 0.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.2 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 1.7 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 1.8 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 0.6 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.2 | 0.2 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 5.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.7 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.4 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 2.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.6 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.4 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.1 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 2.3 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 3.0 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.1 | 0.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 1.5 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.9 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.1 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.1 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.7 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 1.0 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 1.0 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 1.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.8 | GO:1904377 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 1.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.5 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 1.7 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 3.1 | GO:0035690 | cellular response to drug(GO:0035690) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.8 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.1 | 0.1 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 2.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 2.0 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 0.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.6 | GO:0001975 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.3 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.9 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 7.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.6 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 1.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.3 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.3 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 1.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.2 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 3.2 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.1 | 0.3 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.2 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.1 | 0.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 1.6 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.1 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.1 | 5.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 7.0 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 1.0 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.6 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.2 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.2 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.2 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 1.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.2 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 1.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.2 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 2.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 1.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.2 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 1.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.1 | GO:2000341 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.1 | 0.6 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.8 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.1 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.3 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.1 | 0.1 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.1 | 0.1 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 0.1 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.5 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.4 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.1 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.6 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.4 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.2 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.0 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.0 | 0.9 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.0 | 0.0 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.0 | GO:0015809 | arginine transport(GO:0015809) |
0.0 | 0.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 1.0 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.2 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 0.0 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 1.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 1.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:2000380 | regulation of mesoderm development(GO:2000380) |
0.0 | 0.2 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.0 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.0 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.1 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.0 | GO:0060603 | mammary gland duct morphogenesis(GO:0060603) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.0 | GO:0060602 | branch elongation of an epithelium(GO:0060602) |
0.0 | 0.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.0 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.0 | 0.0 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.0 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.8 | GO:0097513 | myosin II filament(GO:0097513) |
2.9 | 17.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.5 | 7.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.3 | 6.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.2 | 6.5 | GO:0097427 | microtubule bundle(GO:0097427) |
2.1 | 4.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.0 | 12.1 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
2.0 | 6.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.8 | 5.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.5 | 5.9 | GO:1990357 | terminal web(GO:1990357) |
1.4 | 4.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.4 | 5.6 | GO:0071953 | elastic fiber(GO:0071953) |
1.3 | 5.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.3 | 11.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.3 | 1.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.2 | 4.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.1 | 3.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.1 | 3.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.1 | 5.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.0 | 1.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.0 | 13.4 | GO:0031430 | M band(GO:0031430) |
1.0 | 2.9 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 11.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.9 | 2.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.9 | 5.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 6.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.9 | 2.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.9 | 6.8 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 14.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 14.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.8 | 2.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.8 | 1.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 2.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.8 | 3.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 3.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.7 | 11.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.7 | 7.0 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 3.5 | GO:0016342 | catenin complex(GO:0016342) |
0.7 | 2.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.7 | 7.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 2.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.6 | 0.6 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.6 | 3.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 10.1 | GO:0030673 | axolemma(GO:0030673) |
0.6 | 26.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.6 | 10.3 | GO:0031672 | A band(GO:0031672) |
0.6 | 2.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 1.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 1.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 1.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.5 | 1.1 | GO:0071546 | pi-body(GO:0071546) |
0.5 | 3.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.5 | 4.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 7.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 9.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 1.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 0.9 | GO:0042641 | actomyosin(GO:0042641) |
0.5 | 1.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 4.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 47.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.5 | 6.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.4 | 2.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 1.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 3.9 | GO:0043034 | costamere(GO:0043034) |
0.4 | 1.7 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 6.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 4.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 2.4 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 3.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 4.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.4 | 1.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 1.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 2.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.4 | 1.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 0.8 | GO:0043256 | laminin complex(GO:0043256) |
0.4 | 3.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 11.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.4 | 2.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 1.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 0.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 1.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 13.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 1.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 4.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 1.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 2.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.0 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 1.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 1.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 0.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 5.8 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 6.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 1.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 9.2 | GO:0016459 | myosin complex(GO:0016459) |
0.3 | 81.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.3 | 2.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 9.7 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 0.8 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 3.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.7 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 14.9 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 1.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 14.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 2.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 3.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 1.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 1.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 0.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 2.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 2.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 2.1 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.6 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 1.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 2.3 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 8.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 0.5 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.7 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 4.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 1.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.5 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 1.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 36.4 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 1.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 1.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 1.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 5.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 7.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 7.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 1.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 3.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.4 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 2.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 11.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 3.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 8.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.5 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 3.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.6 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 9.3 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 3.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.5 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 1.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.8 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 2.1 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.2 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.0 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.7 | 8.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.0 | 6.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.0 | 6.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.8 | 12.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.8 | 5.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.8 | 5.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.6 | 4.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.6 | 4.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.6 | 6.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.5 | 7.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.5 | 7.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.4 | 5.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.4 | 17.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.3 | 4.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.3 | 1.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.3 | 2.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.3 | 3.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.3 | 3.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
1.2 | 8.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.2 | 7.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.2 | 3.6 | GO:0042731 | PH domain binding(GO:0042731) |
1.2 | 7.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.2 | 4.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.1 | 3.4 | GO:0070538 | oleic acid binding(GO:0070538) |
1.1 | 13.5 | GO:0017166 | vinculin binding(GO:0017166) |
1.1 | 14.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.1 | 5.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.1 | 1.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.1 | 11.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.0 | 3.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 3.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.0 | 6.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.0 | 7.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.0 | 6.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.0 | 7.2 | GO:0018642 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.0 | 3.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.0 | 3.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.0 | 4.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.9 | 7.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 4.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 2.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.9 | 3.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.9 | 4.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.9 | 6.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.9 | 3.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.9 | 3.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.9 | 2.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.8 | 2.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.8 | 3.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.8 | 2.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 2.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.8 | 0.8 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.7 | 2.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.7 | 3.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.7 | 2.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.7 | 9.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.7 | 4.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.7 | 2.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 3.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 13.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.7 | 2.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.7 | 20.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.7 | 2.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.7 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 3.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 21.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.7 | 16.1 | GO:0043236 | laminin binding(GO:0043236) |
0.7 | 2.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.7 | 4.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 2.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 3.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.6 | 16.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 0.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.6 | 5.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.6 | 1.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 1.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 8.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 1.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.6 | 2.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 1.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 1.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.6 | 1.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.6 | 1.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 1.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 4.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 4.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 1.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.6 | 6.3 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 4.0 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 2.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 6.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.5 | 6.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 1.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 1.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 2.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 1.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 2.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 1.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 2.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 2.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 2.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.5 | 1.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.5 | 4.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 6.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 2.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 5.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 2.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.5 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 2.4 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 1.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 2.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 1.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 3.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 1.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.5 | 0.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.5 | 5.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.5 | 1.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 4.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 4.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.5 | 9.1 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 0.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 4.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 2.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 4.4 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 1.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 2.2 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.4 | 1.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 3.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 5.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 1.7 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.4 | 1.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 1.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 1.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 2.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 4.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 1.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 33.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.4 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 21.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 1.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 1.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.4 | 1.9 | GO:0035671 | enone reductase activity(GO:0035671) |
0.4 | 2.7 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.4 | 3.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 0.4 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.4 | 2.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 1.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 2.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 3.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 2.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 3.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 1.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.4 | 10.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 2.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 1.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 2.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 1.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 5.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 5.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 63.7 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 3.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 2.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 1.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 1.6 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 3.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 1.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 2.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 3.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 0.9 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 0.9 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 2.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 1.5 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 9.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 0.9 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 0.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 2.3 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 2.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 2.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 1.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 33.2 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.3 | 1.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 1.4 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 0.6 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 1.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 1.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 3.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 2.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 0.8 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.6 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.3 | 1.1 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 5.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 0.3 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 0.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 1.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 0.8 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.3 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.2 | 1.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 15.3 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 3.9 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 1.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 1.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 1.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.7 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 1.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 1.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.8 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.2 | 2.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.6 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.8 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 2.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 1.4 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 1.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 2.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.5 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 3.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 5.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 2.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 13.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 4.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 1.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 1.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 4.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.7 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 1.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 2.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 2.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 1.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.6 | GO:0098632 | protein binding involved in cell adhesion(GO:0098631) protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 2.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.4 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.5 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 1.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.1 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.7 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 1.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 3.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 3.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 2.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.3 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 2.3 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 1.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 1.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 2.7 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 3.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.1 | GO:0018559 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 3.4 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 6.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 1.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 1.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 9.4 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.0 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.2 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.0 | 0.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 15.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.2 | 31.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 14.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.0 | 44.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.8 | 18.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.7 | 11.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.7 | 19.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 1.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 1.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 27.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 2.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.6 | 7.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 5.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 4.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 10.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.5 | 9.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 13.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 3.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 7.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 1.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 3.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 9.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 12.1 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 52.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 4.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 10.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 4.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 8.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 2.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 3.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 4.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 2.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 3.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 13.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 5.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 7.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 8.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 1.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 5.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 6.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 7.7 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 33.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 0.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 3.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 3.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 4.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 7.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 4.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 5.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 4.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 2.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 26.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 3.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 3.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 2.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 2.4 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 3.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.4 | 15.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.2 | 1.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.1 | 38.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.0 | 25.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.9 | 47.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.9 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.8 | 1.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.8 | 0.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.8 | 15.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.8 | 14.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.7 | 3.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 1.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.6 | 13.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 16.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 2.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 2.3 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.5 | 5.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 11.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.5 | 10.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 5.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 4.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 2.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.5 | 19.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.5 | 1.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 5.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 8.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 5.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 4.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.4 | 1.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.4 | 17.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 4.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 1.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 3.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 3.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 34.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 6.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 3.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 6.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 18.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 3.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 1.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.3 | 25.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 3.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 1.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 1.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 3.0 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.3 | 2.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 2.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 1.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 4.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 2.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 1.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 0.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 2.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 0.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 5.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 4.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 2.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.3 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.1 | 1.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 1.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 3.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.3 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |